Put your challenging affinity screening campaigns back on track — after you’ve tried everything else

September 27, 2022

When you’re entrusted with developing therapeutics for challenging or undruggable targets, it’s a struggle to characterize molecular interactions. And it’s not for lack of effort or expertise — SPR and other methods have either failed or have given noisy, unreliable affinity data. When it’s not clear which hits to advance, the pressure is on and you feel you are running out of options.

Watch this online event to discover how Dianthus — a plate-based affinity screening platform with breakthrough Spectral Shift technology — removes the limitations that get in the way of your screening campaign's success.

In this event you will:

  • Learn how to finally move your screening campaigns forward with direct affinity measurements in solution and reduced assay development
  • See data from case studies using Dianthus for challenging applications like PROTACs ternary complex, hook effect, and undruggable KRAS
  • Take a tour of Dianthus to learn about assay setup and get a quick peek into single-point screening data analysis
Previous Video
Selective degradation of cancer target WDR5 — Evaluation of PROTACs binary and ternary affinities with Spectral Shift
Selective degradation of cancer target WDR5 — Evaluation of PROTACs binary and ternary affinities with Spectral Shift

Chances are your company’s research and development pipeline includes several PROTAC candidates — placing y...

Up next
NanoTemper Technologies launches Spectral Shift, a breakthrough technology that changes the game for affinity-based screenings
NanoTemper Technologies launches Spectral Shift, a breakthrough technology that changes the game for affinity-based screenings

NanoTemper Technologies, announced today the launch of Spectral Shift technology within their Dianthus inst...

Ready to tackle your challenging affinity screening?

Discover tools you can use

Learn more